Table 2.
Age | Acylcarnitines [μmol/l] | Dicarboxylic Acids in Urine | Molecular Genetics | |||
---|---|---|---|---|---|---|
C16-OH (c) | C18:1-OH (c) | |||||
Patient 1 | HADHA gene: c.1528G > C (p.E510Q), homozygous | |||||
2 daysa | 1.62 | (< 0.05) | 0.46 | (< 0.04) | ||
11 daysa | 0.49 | (< 0.05) | 0.29 | (< 0.04) | normal | |
4 monthsb | 15.41 | (< 0.17) | 10.67 | (< 0.10) | elevated | |
Patient 2 | HADHB gene: c.1198G > T (p.E400X)/c.442 + 663A > G, compound heterozygous | |||||
2 daysa | 0.35 | (< 0.05) | 0.06 | (< 0.04) | ||
7 daysa | 0.44 | (< 0.05) | 0.08 | (< 0.04) | normal | |
8 monthsb | 0.045 | (< 0.01) | 0.055 | (< 0.01) | elevated | |
Patient 3 | HADHA gene: c.1528G > C (p.E510Q), homozygous | |||||
5 daysa | 0.31 | (< 0.12) | 0.47 | (< 0.16) | n.a. | |
5 monthsb | 0.98 | (< 0.10) | 0.74 | (< 0.10) | elevated |
Symbols and abbreviations are as follows: a filter paper, b plasma, collected in metabolic decompensation, ccut-off, n.a. = not available